Diana Isaacs, PharmD, and Natalie Bellini, DNP, review early MiniMed Vivera data on optional meal announcements and twiist's new type 2 diabetes clearance.
|Podcasts|September 2, 2020
Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients
Author(s)Patrick Campbell
A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.
Advertisement
In this episode of the Endocrine Outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results of
Results of the study suggest individual components on metabolic syndrome were not associated with worse outcomes but their combined presence in the form of metabolic syndrome resulted in more severe outcomes among their patient population.
Advertisement
Related to this article
Lorundrostat cut systolic BP by 9.6 mm Hg and UACR by 52.2% vs placebo in participants with CKD and uncontrolled hypertension in Launch-HTN.
The ENRICH-AF trial ultimately did not demonstrate edoxaban’s efficacy, highlighting the need for further stroke prevention strategies for this patient population.
A recent MRI analysis of the pivotal OCEANIC-STROKE trial has indicated a complete lack of association between infarct patterns and asundexian’s efficacy.
A new analysis of 4 major trials has revealed the association between lower SBP and higher TTR and the risk of recurrent stroke after intracerebral hemorrhage.
Data from the phase 2a BIRCH trial demonstrated the treatment’s improvements in mRS and NLR, positioning it for a late-phase trial in the future.
A new analysis of the BRIDGE-TNK trial has demonstrated that patients with cardioembolism are more likely to derive benefit than those with large artery atherosclerosis.
Advertisement
Advertisement
Trending on HCPLive
1
eGFR Underestimates CKD in Patients with Cancer, Study Finds
2
Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant
3
ATTACK: Should Patients With CKD Start Aspirin for Primary Prevention?
4
GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD
5